Churchill Downs, GoodRx, and Schrödinger Report 2025 Full-Year Performance
Churchill Downs, GoodRx, and Schrödinger released their 2025 fourth-quarter and full-year financial results, highlighting a year of strategic expansion in gaming, healthcare technology, and AI-driven drug discovery. The reports reflect a broader market trend of resilient consumer spending in entertainment and the increasing integration of software-as-a-service (SaaS) models in specialized industries.